Zhang et al. studied the link between PD-1/PD-L1 expression and posttreatment results in NPC patients and found increased levels of PD-L1 expression in the malignant tissues of NPC patients [42]. The gene discussed is CD274; the disease is nasopharyngeal carcinoma.